Global Peptide API CDMO Services Market Growth (Status and Outlook) 2024-2030--LP INFORMATION, INC.

Global Peptide API CDMO Services Market Growth (Status and Outlook) 2024-2030

Product Code: 981512

Industry: Medical Devices & Consumables

Published: Jun 20,2024

Pages: 104

Delivery Time: 2-3 business days

Global Peptide API CDMO Services Market Growth (Status and Outlook) 2024-2030

Product Code: 981512

Industry: Medical Devices & Consumables

Published: Jun 20,2024

Pages: 104

Delivery Time: 2-3 business days

Select A Format

Single User License

USD3660

Multi Users License

USD5490

Corporate Users License

USD7320

Buy Now

Add To Cart

Or More Options：

PDF Download

Sample Request

Custom Request

Provide market analysis and obtain sources of data reports

Description

Peptide API CDMO (Contract Development and Manufacturing Organization) Services refer to the specialized services provided by companies that offer comprehensive support for the development, manufacturing, and production of peptide active pharmaceutical ingredients (APIs). These services are essential for the pharmaceutical and biotechnology industries, facilitating the production of peptides for therapeutic purposes.

The global Peptide API CDMO Services market size is projected to grow from US$ 2291 million in 2024 to US$ 5489 million in 2030; it is expected to grow at a CAGR of 15.7% from 2024 to 2030.

LPI (LP Information)' newest research report, the “Peptide API CDMO Services Industry Forecast” looks at past sales and reviews total world Peptide API CDMO Services sales in 2022, providing a comprehensive analysis by region and market sector of projected Peptide API CDMO Services sales for 2023 through 2029. With Peptide API CDMO Services sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Peptide API CDMO Services industry.

This Insight Report provides a comprehensive analysis of the global Peptide API CDMO Services landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Peptide API CDMO Services portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Peptide API CDMO Services market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Peptide API CDMO Services and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Peptide API CDMO Services.

Global key players of Peptide API CDMO Services include Bachem, PolyPeptide, CordenPharma, AmbioPharm, Thermo Fisher, etc. The top five players hold a share over 54%. North America is the largest market, and has a share about 52%, followed by Europe and China with share 33% and 9%, separately. In terms of product type, GMP Services is the largest segment, occupied for a share of 72%. In terms of application, Commercial has a share about 75 percent.

This report presents a comprehensive overview, market shares, and growth opportunities of Peptide API CDMO Services market by product type, application, key players and key regions and countries.

Segmentation by Type:

    GMP Services

    Non-GMP Services

Segmentation by Application:

    Commercial

    Scientific Research

    Other

This report also splits the market by region:

    Americas

    United States

    Canada

    Mexico

    Brazil

    APAC

    China

    Japan

    Korea

    Southeast Asia

    India

    Australia

    Europe

    Germany

    France

UK

    Italy

    Russia

    Middle East & Africa

    Egypt

    South Africa

    Israel

    Turkey

    GCC Countries

Segmentation by Type:

    GMP Services

    Non-GMP Services

Segmentation by Application:

    Commercial

    Scientific Research

    Other

This report also splits the market by region:

    Americas

    United States

    Canada

    Mexico

    Brazil

    APAC

    China

    Japan

    Korea

    Southeast Asia

    India

    Australia

    Europe

    Germany

    France

UK

    Italy

    Russia

    Middle East & Africa

    Egypt

    South Africa

    Israel

    Turkey

    GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

    Bachem

    PolyPeptide

    CordenPharma

    AmbioPharm

    USV Peptides

    Thermo Fisher

    Bio Basic

JPT

    Genscript

    Chinese Peptide Company

    ScinoPharm

    ChengDu ShengNuo Biotec

CBL

    Piramal Pharma

    CPC Scientific

Table Of Contents

1 Scope of the Report
    1.1 Market Introduction
    1.2 Years Considered
    1.3 Research Objectives
    1.4 Market Research Methodology
    1.5 Research Process and Data Source
    1.6 Economic Indicators
    1.7 Currency Considered
    1.8 Market Estimation Caveats

2 Executive Summary
    2.1 World Market Overview
        2.1.1 Global Peptide API CDMO Services Market Size 2019-2030
        2.1.2 Peptide API CDMO Services Market Size CAGR by Region (2019 VS 2023 VS 2030)
        2.1.3 World Current & Future Analysis for Peptide API CDMO Services by Country/Region, 2019, 2023 & 2030
    2.2 Peptide API CDMO Services Segment by Type
        2.2.1 GMP Services
        2.2.2 Non-GMP Services
    2.3 Peptide API CDMO Services Market Size by Type
        2.3.1 Peptide API CDMO Services Market Size CAGR by Type (2019 VS 2023 VS 2030)
        2.3.2 Global Peptide API CDMO Services Market Size Market Share by Type (2019-2024)
    2.4 Peptide API CDMO Services Segment by Application
        2.4.1 Commercial
        2.4.2 Scientific Research
        2.4.3 Other
    2.5 Peptide API CDMO Services Market Size by Application
        2.5.1 Peptide API CDMO Services Market Size CAGR by Application (2019 VS 2023 VS 2030)
        2.5.2 Global Peptide API CDMO Services Market Size Market Share by Application (2019-2024)

3 Peptide API CDMO Services Market Size by Player
    3.1 Peptide API CDMO Services Market Size Market Share by Player
        3.1.1 Global Peptide API CDMO Services Revenue by Player (2019-2024)
        3.1.2 Global Peptide API CDMO Services Revenue Market Share by Player (2019-2024)
    3.2 Global Peptide API CDMO Services Key Players Head office and Products Offered
    3.3 Market Concentration Rate Analysis
        3.3.1 Competition Landscape Analysis
        3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
    3.4 New Products and Potential Entrants
    3.5 Mergers & Acquisitions, Expansion

4 Peptide API CDMO Services by Region
    4.1 Peptide API CDMO Services Market Size by Region (2019-2024)
    4.2 Global Peptide API CDMO Services Annual Revenue by Country/Region (2019-2024)
    4.3 Americas Peptide API CDMO Services Market Size Growth (2019-2024)
    4.4 APAC Peptide API CDMO Services Market Size Growth (2019-2024)
    4.5 Europe Peptide API CDMO Services Market Size Growth (2019-2024)
    4.6 Middle East & Africa Peptide API CDMO Services Market Size Growth (2019-2024)

5 Americas
    5.1 Americas Peptide API CDMO Services Market Size by Country (2019-2024)
    5.2 Americas Peptide API CDMO Services Market Size by Type (2019-2024)
    5.3 Americas Peptide API CDMO Services Market Size by Application (2019-2024)
    5.4 United States
    5.5 Canada
    5.6 Mexico
    5.7 Brazil

6 APAC
    6.1 APAC Peptide API CDMO Services Market Size by Region (2019-2024)
    6.2 APAC Peptide API CDMO Services Market Size by Type (2019-2024)
    6.3 APAC Peptide API CDMO Services Market Size by Application (2019-2024)
    6.4 China
    6.5 Japan
    6.6 South Korea
    6.7 Southeast Asia
    6.8 India
    6.9 Australia

7 Europe
    7.1 Europe Peptide API CDMO Services Market Size by Country (2019-2024)
    7.2 Europe Peptide API CDMO Services Market Size by Type (2019-2024)
    7.3 Europe Peptide API CDMO Services Market Size by Application (2019-2024)
    7.4 Germany
    7.5 France
    7.6 UK
    7.7 Italy
    7.8 Russia

8 Middle East & Africa
    8.1 Middle East & Africa Peptide API CDMO Services by Region (2019-2024)
    8.2 Middle East & Africa Peptide API CDMO Services Market Size by Type (2019-2024)
    8.3 Middle East & Africa Peptide API CDMO Services Market Size by Application (2019-2024)
    8.4 Egypt
    8.5 South Africa
    8.6 Israel
    8.7 Turkey
    8.8 GCC Countries

9 Market Drivers, Challenges and Trends
    9.1 Market Drivers & Growth Opportunities
    9.2 Market Challenges & Risks
    9.3 Industry Trends

10 Global Peptide API CDMO Services Market Forecast
    10.1 Global Peptide API CDMO Services Forecast by Region (2025-2030)
        10.1.1 Global Peptide API CDMO Services Forecast by Region (2025-2030)
        10.1.2 Americas Peptide API CDMO Services Forecast
        10.1.3 APAC Peptide API CDMO Services Forecast
        10.1.4 Europe Peptide API CDMO Services Forecast
        10.1.5 Middle East & Africa Peptide API CDMO Services Forecast
    10.2 Americas Peptide API CDMO Services Forecast by Country (2025-2030)
        10.2.1 United States Market Peptide API CDMO Services Forecast
        10.2.2 Canada Market Peptide API CDMO Services Forecast
        10.2.3 Mexico Market Peptide API CDMO Services Forecast
        10.2.4 Brazil Market Peptide API CDMO Services Forecast
    10.3 APAC Peptide API CDMO Services Forecast by Region (2025-2030)
        10.3.1 China Peptide API CDMO Services Market Forecast
        10.3.2 Japan Market Peptide API CDMO Services Forecast
        10.3.3 Korea Market Peptide API CDMO Services Forecast
        10.3.4 Southeast Asia Market Peptide API CDMO Services Forecast
        10.3.5 India Market Peptide API CDMO Services Forecast
        10.3.6 Australia Market Peptide API CDMO Services Forecast
    10.4 Europe Peptide API CDMO Services Forecast by Country (2025-2030)
        10.4.1 Germany Market Peptide API CDMO Services Forecast
        10.4.2 France Market Peptide API CDMO Services Forecast
        10.4.3 UK Market Peptide API CDMO Services Forecast
        10.4.4 Italy Market Peptide API CDMO Services Forecast
        10.4.5 Russia Market Peptide API CDMO Services Forecast
    10.5 Middle East & Africa Peptide API CDMO Services Forecast by Region (2025-2030)
        10.5.1 Egypt Market Peptide API CDMO Services Forecast
        10.5.2 South Africa Market Peptide API CDMO Services Forecast
        10.5.3 Israel Market Peptide API CDMO Services Forecast
        10.5.4 Turkey Market Peptide API CDMO Services Forecast
    10.6 Global Peptide API CDMO Services Forecast by Type (2025-2030)
    10.7 Global Peptide API CDMO Services Forecast by Application (2025-2030)
        10.7.1 GCC Countries Market Peptide API CDMO Services Forecast

11 Key Players Analysis
    11.1 Bachem
        11.1.1 Bachem Company Information
        11.1.2 Bachem Peptide API CDMO Services Product Offered
        11.1.3 Bachem Peptide API CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
        11.1.4 Bachem Main Business Overview
        11.1.5 Bachem Latest Developments
    11.2 PolyPeptide
        11.2.1 PolyPeptide Company Information
        11.2.2 PolyPeptide Peptide API CDMO Services Product Offered
        11.2.3 PolyPeptide Peptide API CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
        11.2.4 PolyPeptide Main Business Overview
        11.2.5 PolyPeptide Latest Developments
    11.3 CordenPharma
        11.3.1 CordenPharma Company Information
        11.3.2 CordenPharma Peptide API CDMO Services Product Offered
        11.3.3 CordenPharma Peptide API CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
        11.3.4 CordenPharma Main Business Overview
        11.3.5 CordenPharma Latest Developments
    11.4 AmbioPharm
        11.4.1 AmbioPharm Company Information
        11.4.2 AmbioPharm Peptide API CDMO Services Product Offered
        11.4.3 AmbioPharm Peptide API CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
        11.4.4 AmbioPharm Main Business Overview
        11.4.5 AmbioPharm Latest Developments
    11.5 USV Peptides
        11.5.1 USV Peptides Company Information
        11.5.2 USV Peptides Peptide API CDMO Services Product Offered
        11.5.3 USV Peptides Peptide API CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
        11.5.4 USV Peptides Main Business Overview
        11.5.5 USV Peptides Latest Developments
    11.6 Thermo Fisher
        11.6.1 Thermo Fisher Company Information
        11.6.2 Thermo Fisher Peptide API CDMO Services Product Offered
        11.6.3 Thermo Fisher Peptide API CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
        11.6.4 Thermo Fisher Main Business Overview
        11.6.5 Thermo Fisher Latest Developments
    11.7 Bio Basic
        11.7.1 Bio Basic Company Information
        11.7.2 Bio Basic Peptide API CDMO Services Product Offered
        11.7.3 Bio Basic Peptide API CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
        11.7.4 Bio Basic Main Business Overview
        11.7.5 Bio Basic Latest Developments
    11.8 JPT
        11.8.1 JPT Company Information
        11.8.2 JPT Peptide API CDMO Services Product Offered
        11.8.3 JPT Peptide API CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
        11.8.4 JPT Main Business Overview
        11.8.5 JPT Latest Developments
    11.9 Genscript
        11.9.1 Genscript Company Information
        11.9.2 Genscript Peptide API CDMO Services Product Offered
        11.9.3 Genscript Peptide API CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
        11.9.4 Genscript Main Business Overview
        11.9.5 Genscript Latest Developments
    11.10 Chinese Peptide Company
        11.10.1 Chinese Peptide Company Company Information
        11.10.2 Chinese Peptide Company Peptide API CDMO Services Product Offered
        11.10.3 Chinese Peptide Company Peptide API CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
        11.10.4 Chinese Peptide Company Main Business Overview
        11.10.5 Chinese Peptide Company Latest Developments
    11.11 ScinoPharm
        11.11.1 ScinoPharm Company Information
        11.11.2 ScinoPharm Peptide API CDMO Services Product Offered
        11.11.3 ScinoPharm Peptide API CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
        11.11.4 ScinoPharm Main Business Overview
        11.11.5 ScinoPharm Latest Developments
    11.12 ChengDu ShengNuo Biotec
        11.12.1 ChengDu ShengNuo Biotec Company Information
        11.12.2 ChengDu ShengNuo Biotec Peptide API CDMO Services Product Offered
        11.12.3 ChengDu ShengNuo Biotec Peptide API CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
        11.12.4 ChengDu ShengNuo Biotec Main Business Overview
        11.12.5 ChengDu ShengNuo Biotec Latest Developments
    11.13 CBL
        11.13.1 CBL Company Information
        11.13.2 CBL Peptide API CDMO Services Product Offered
        11.13.3 CBL Peptide API CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
        11.13.4 CBL Main Business Overview
        11.13.5 CBL Latest Developments
    11.14 Piramal Pharma
        11.14.1 Piramal Pharma Company Information
        11.14.2 Piramal Pharma Peptide API CDMO Services Product Offered
        11.14.3 Piramal Pharma Peptide API CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
        11.14.4 Piramal Pharma Main Business Overview
        11.14.5 Piramal Pharma Latest Developments
    11.15 CPC Scientific
        11.15.1 CPC Scientific Company Information
        11.15.2 CPC Scientific Peptide API CDMO Services Product Offered
        11.15.3 CPC Scientific Peptide API CDMO Services Revenue, Gross Margin and Market Share (2019-2024)
        11.15.4 CPC Scientific Main Business Overview
        11.15.5 CPC Scientific Latest Developments

12 Research Findings and Conclusion

List Of Tables

List of Tables
 Table 1. Peptide API CDMO Services Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ millions)
 Table 2. Peptide API CDMO Services Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
 Table 3. Major Players of GMP Services
 Table 4. Major Players of Non-GMP Services
 Table 5. Peptide API CDMO Services Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ millions)
 Table 6. Global Peptide API CDMO Services Market Size by Type (2019-2024) & ($ millions)
 Table 7. Global Peptide API CDMO Services Market Size Market Share by Type (2019-2024)
 Table 8. Peptide API CDMO Services Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ millions)
 Table 9. Global Peptide API CDMO Services Market Size by Application (2019-2024) & ($ millions)
 Table 10. Global Peptide API CDMO Services Market Size Market Share by Application (2019-2024)
 Table 11. Global Peptide API CDMO Services Revenue by Player (2019-2024) & ($ millions)
 Table 12. Global Peptide API CDMO Services Revenue Market Share by Player (2019-2024)
 Table 13. Peptide API CDMO Services Key Players Head office and Products Offered
 Table 14. Peptide API CDMO Services Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
 Table 15. New Products and Potential Entrants
 Table 16. Mergers & Acquisitions, Expansion
 Table 17. Global Peptide API CDMO Services Market Size by Region (2019-2024) & ($ millions)
 Table 18. Global Peptide API CDMO Services Market Size Market Share by Region (2019-2024)
 Table 19. Global Peptide API CDMO Services Revenue by Country/Region (2019-2024) & ($ millions)
 Table 20. Global Peptide API CDMO Services Revenue Market Share by Country/Region (2019-2024)
 Table 21. Americas Peptide API CDMO Services Market Size by Country (2019-2024) & ($ millions)
 Table 22. Americas Peptide API CDMO Services Market Size Market Share by Country (2019-2024)
 Table 23. Americas Peptide API CDMO Services Market Size by Type (2019-2024) & ($ millions)
 Table 24. Americas Peptide API CDMO Services Market Size Market Share by Type (2019-2024)
 Table 25. Americas Peptide API CDMO Services Market Size by Application (2019-2024) & ($ millions)
 Table 26. Americas Peptide API CDMO Services Market Size Market Share by Application (2019-2024)
 Table 27. APAC Peptide API CDMO Services Market Size by Region (2019-2024) & ($ millions)
 Table 28. APAC Peptide API CDMO Services Market Size Market Share by Region (2019-2024)
 Table 29. APAC Peptide API CDMO Services Market Size by Type (2019-2024) & ($ millions)
 Table 30. APAC Peptide API CDMO Services Market Size by Application (2019-2024) & ($ millions)
 Table 31. Europe Peptide API CDMO Services Market Size by Country (2019-2024) & ($ millions)
 Table 32. Europe Peptide API CDMO Services Market Size Market Share by Country (2019-2024)
 Table 33. Europe Peptide API CDMO Services Market Size by Type (2019-2024) & ($ millions)
 Table 34. Europe Peptide API CDMO Services Market Size by Application (2019-2024) & ($ millions)
 Table 35. Middle East & Africa Peptide API CDMO Services Market Size by Region (2019-2024) & ($ millions)
 Table 36. Middle East & Africa Peptide API CDMO Services Market Size by Type (2019-2024) & ($ millions)
 Table 37. Middle East & Africa Peptide API CDMO Services Market Size by Application (2019-2024) & ($ millions)
 Table 38. Key Market Drivers & Growth Opportunities of Peptide API CDMO Services
 Table 39. Key Market Challenges & Risks of Peptide API CDMO Services
 Table 40. Key Industry Trends of Peptide API CDMO Services
 Table 41. Global Peptide API CDMO Services Market Size Forecast by Region (2025-2030) & ($ millions)
 Table 42. Global Peptide API CDMO Services Market Size Market Share Forecast by Region (2025-2030)
 Table 43. Global Peptide API CDMO Services Market Size Forecast by Type (2025-2030) & ($ millions)
 Table 44. Global Peptide API CDMO Services Market Size Forecast by Application (2025-2030) & ($ millions)
 Table 45. Bachem Details, Company Type, Peptide API CDMO Services Area Served and Its Competitors
 Table 46. Bachem Peptide API CDMO Services Product Offered
 Table 47. Bachem Peptide API CDMO Services Revenue ($ million), Gross Margin and Market Share (2019-2024)
 Table 48. Bachem Main Business
 Table 49. Bachem Latest Developments
 Table 50. PolyPeptide Details, Company Type, Peptide API CDMO Services Area Served and Its Competitors
 Table 51. PolyPeptide Peptide API CDMO Services Product Offered
 Table 52. PolyPeptide Peptide API CDMO Services Revenue ($ million), Gross Margin and Market Share (2019-2024)
 Table 53. PolyPeptide Main Business
 Table 54. PolyPeptide Latest Developments
 Table 55. CordenPharma Details, Company Type, Peptide API CDMO Services Area Served and Its Competitors
 Table 56. CordenPharma Peptide API CDMO Services Product Offered
 Table 57. CordenPharma Peptide API CDMO Services Revenue ($ million), Gross Margin and Market Share (2019-2024)
 Table 58. CordenPharma Main Business
 Table 59. CordenPharma Latest Developments
 Table 60. AmbioPharm Details, Company Type, Peptide API CDMO Services Area Served and Its Competitors
 Table 61. AmbioPharm Peptide API CDMO Services Product Offered
 Table 62. AmbioPharm Peptide API CDMO Services Revenue ($ million), Gross Margin and Market Share (2019-2024)
 Table 63. AmbioPharm Main Business
 Table 64. AmbioPharm Latest Developments
 Table 65. USV Peptides Details, Company Type, Peptide API CDMO Services Area Served and Its Competitors
 Table 66. USV Peptides Peptide API CDMO Services Product Offered
 Table 67. USV Peptides Peptide API CDMO Services Revenue ($ million), Gross Margin and Market Share (2019-2024)
 Table 68. USV Peptides Main Business
 Table 69. USV Peptides Latest Developments
 Table 70. Thermo Fisher Details, Company Type, Peptide API CDMO Services Area Served and Its Competitors
 Table 71. Thermo Fisher Peptide API CDMO Services Product Offered
 Table 72. Thermo Fisher Peptide API CDMO Services Revenue ($ million), Gross Margin and Market Share (2019-2024)
 Table 73. Thermo Fisher Main Business
 Table 74. Thermo Fisher Latest Developments
 Table 75. Bio Basic Details, Company Type, Peptide API CDMO Services Area Served and Its Competitors
 Table 76. Bio Basic Peptide API CDMO Services Product Offered
 Table 77. Bio Basic Peptide API CDMO Services Revenue ($ million), Gross Margin and Market Share (2019-2024)
 Table 78. Bio Basic Main Business
 Table 79. Bio Basic Latest Developments
 Table 80. JPT Details, Company Type, Peptide API CDMO Services Area Served and Its Competitors
 Table 81. JPT Peptide API CDMO Services Product Offered
 Table 82. JPT Peptide API CDMO Services Revenue ($ million), Gross Margin and Market Share (2019-2024)
 Table 83. JPT Main Business
 Table 84. JPT Latest Developments
 Table 85. Genscript Details, Company Type, Peptide API CDMO Services Area Served and Its Competitors
 Table 86. Genscript Peptide API CDMO Services Product Offered
 Table 87. Genscript Peptide API CDMO Services Revenue ($ million), Gross Margin and Market Share (2019-2024)
 Table 88. Genscript Main Business
 Table 89. Genscript Latest Developments
 Table 90. Chinese Peptide Company Details, Company Type, Peptide API CDMO Services Area Served and Its Competitors
 Table 91. Chinese Peptide Company Peptide API CDMO Services Product Offered
 Table 92. Chinese Peptide Company Peptide API CDMO Services Revenue ($ million), Gross Margin and Market Share (2019-2024)
 Table 93. Chinese Peptide Company Main Business
 Table 94. Chinese Peptide Company Latest Developments
 Table 95. ScinoPharm Details, Company Type, Peptide API CDMO Services Area Served and Its Competitors
 Table 96. ScinoPharm Peptide API CDMO Services Product Offered
 Table 97. ScinoPharm Peptide API CDMO Services Revenue ($ million), Gross Margin and Market Share (2019-2024)
 Table 98. ScinoPharm Main Business
 Table 99. ScinoPharm Latest Developments
 Table 100. ChengDu ShengNuo Biotec Details, Company Type, Peptide API CDMO Services Area Served and Its Competitors
 Table 101. ChengDu ShengNuo Biotec Peptide API CDMO Services Product Offered
 Table 102. ChengDu ShengNuo Biotec Peptide API CDMO Services Revenue ($ million), Gross Margin and Market Share (2019-2024)
 Table 103. ChengDu ShengNuo Biotec Main Business
 Table 104. ChengDu ShengNuo Biotec Latest Developments
 Table 105. CBL Details, Company Type, Peptide API CDMO Services Area Served and Its Competitors
 Table 106. CBL Peptide API CDMO Services Product Offered
 Table 107. CBL Peptide API CDMO Services Revenue ($ million), Gross Margin and Market Share (2019-2024)
 Table 108. CBL Main Business
 Table 109. CBL Latest Developments
 Table 110. Piramal Pharma Details, Company Type, Peptide API CDMO Services Area Served and Its Competitors
 Table 111. Piramal Pharma Peptide API CDMO Services Product Offered
 Table 112. Piramal Pharma Peptide API CDMO Services Revenue ($ million), Gross Margin and Market Share (2019-2024)
 Table 113. Piramal Pharma Main Business
 Table 114. Piramal Pharma Latest Developments
 Table 115. CPC Scientific Details, Company Type, Peptide API CDMO Services Area Served and Its Competitors
 Table 116. CPC Scientific Peptide API CDMO Services Product Offered
 Table 117. CPC Scientific Peptide API CDMO Services Revenue ($ million), Gross Margin and Market Share (2019-2024)
 Table 118. CPC Scientific Main Business
 Table 119. CPC Scientific Latest Developments


List of Figures
 Figure 1. Peptide API CDMO Services Report Years Considered
 Figure 2. Research Objectives
 Figure 3. Research Methodology
 Figure 4. Research Process and Data Source
 Figure 5. Global Peptide API CDMO Services Market Size Growth Rate 2019-2030 ($ millions)
 Figure 6. Peptide API CDMO Services Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
 Figure 7. Peptide API CDMO Services Sales Market Share by Country/Region (2023)
 Figure 8. Peptide API CDMO Services Sales Market Share by Country/Region (2019, 2023 & 2030)
 Figure 9. Global Peptide API CDMO Services Market Size Market Share by Type in 2023
 Figure 10. Peptide API CDMO Services in Commercial
 Figure 11. Global Peptide API CDMO Services Market: Commercial (2019-2024) & ($ millions)
 Figure 12. Peptide API CDMO Services in Scientific Research
 Figure 13. Global Peptide API CDMO Services Market: Scientific Research (2019-2024) & ($ millions)
 Figure 14. Peptide API CDMO Services in Other
 Figure 15. Global Peptide API CDMO Services Market: Other (2019-2024) & ($ millions)
 Figure 16. Global Peptide API CDMO Services Market Size Market Share by Application in 2023
 Figure 17. Global Peptide API CDMO Services Revenue Market Share by Player in 2023
 Figure 18. Global Peptide API CDMO Services Market Size Market Share by Region (2019-2024)
 Figure 19. Americas Peptide API CDMO Services Market Size 2019-2024 ($ millions)
 Figure 20. APAC Peptide API CDMO Services Market Size 2019-2024 ($ millions)
 Figure 21. Europe Peptide API CDMO Services Market Size 2019-2024 ($ millions)
 Figure 22. Middle East & Africa Peptide API CDMO Services Market Size 2019-2024 ($ millions)
 Figure 23. Americas Peptide API CDMO Services Value Market Share by Country in 2023
 Figure 24. United States Peptide API CDMO Services Market Size Growth 2019-2024 ($ millions)
 Figure 25. Canada Peptide API CDMO Services Market Size Growth 2019-2024 ($ millions)
 Figure 26. Mexico Peptide API CDMO Services Market Size Growth 2019-2024 ($ millions)
 Figure 27. Brazil Peptide API CDMO Services Market Size Growth 2019-2024 ($ millions)
 Figure 28. APAC Peptide API CDMO Services Market Size Market Share by Region in 2023
 Figure 29. APAC Peptide API CDMO Services Market Size Market Share by Type (2019-2024)
 Figure 30. APAC Peptide API CDMO Services Market Size Market Share by Application (2019-2024)
 Figure 31. China Peptide API CDMO Services Market Size Growth 2019-2024 ($ millions)
 Figure 32. Japan Peptide API CDMO Services Market Size Growth 2019-2024 ($ millions)
 Figure 33. South Korea Peptide API CDMO Services Market Size Growth 2019-2024 ($ millions)
 Figure 34. Southeast Asia Peptide API CDMO Services Market Size Growth 2019-2024 ($ millions)
 Figure 35. India Peptide API CDMO Services Market Size Growth 2019-2024 ($ millions)
 Figure 36. Australia Peptide API CDMO Services Market Size Growth 2019-2024 ($ millions)
 Figure 37. Europe Peptide API CDMO Services Market Size Market Share by Country in 2023
 Figure 38. Europe Peptide API CDMO Services Market Size Market Share by Type (2019-2024)
 Figure 39. Europe Peptide API CDMO Services Market Size Market Share by Application (2019-2024)
 Figure 40. Germany Peptide API CDMO Services Market Size Growth 2019-2024 ($ millions)
 Figure 41. France Peptide API CDMO Services Market Size Growth 2019-2024 ($ millions)
 Figure 42. UK Peptide API CDMO Services Market Size Growth 2019-2024 ($ millions)
 Figure 43. Italy Peptide API CDMO Services Market Size Growth 2019-2024 ($ millions)
 Figure 44. Russia Peptide API CDMO Services Market Size Growth 2019-2024 ($ millions)
 Figure 45. Middle East & Africa Peptide API CDMO Services Market Size Market Share by Region (2019-2024)
 Figure 46. Middle East & Africa Peptide API CDMO Services Market Size Market Share by Type (2019-2024)
 Figure 47. Middle East & Africa Peptide API CDMO Services Market Size Market Share by Application (2019-2024)
 Figure 48. Egypt Peptide API CDMO Services Market Size Growth 2019-2024 ($ millions)
 Figure 49. South Africa Peptide API CDMO Services Market Size Growth 2019-2024 ($ millions)
 Figure 50. Israel Peptide API CDMO Services Market Size Growth 2019-2024 ($ millions)
 Figure 51. Turkey Peptide API CDMO Services Market Size Growth 2019-2024 ($ millions)
 Figure 52. GCC Countries Peptide API CDMO Services Market Size Growth 2019-2024 ($ millions)
 Figure 53. Americas Peptide API CDMO Services Market Size 2025-2030 ($ millions)
 Figure 54. APAC Peptide API CDMO Services Market Size 2025-2030 ($ millions)
 Figure 55. Europe Peptide API CDMO Services Market Size 2025-2030 ($ millions)
 Figure 56. Middle East & Africa Peptide API CDMO Services Market Size 2025-2030 ($ millions)
 Figure 57. United States Peptide API CDMO Services Market Size 2025-2030 ($ millions)
 Figure 58. Canada Peptide API CDMO Services Market Size 2025-2030 ($ millions)
 Figure 59. Mexico Peptide API CDMO Services Market Size 2025-2030 ($ millions)
 Figure 60. Brazil Peptide API CDMO Services Market Size 2025-2030 ($ millions)
 Figure 61. China Peptide API CDMO Services Market Size 2025-2030 ($ millions)
 Figure 62. Japan Peptide API CDMO Services Market Size 2025-2030 ($ millions)
 Figure 63. Korea Peptide API CDMO Services Market Size 2025-2030 ($ millions)
 Figure 64. Southeast Asia Peptide API CDMO Services Market Size 2025-2030 ($ millions)
 Figure 65. India Peptide API CDMO Services Market Size 2025-2030 ($ millions)
 Figure 66. Australia Peptide API CDMO Services Market Size 2025-2030 ($ millions)
 Figure 67. Germany Peptide API CDMO Services Market Size 2025-2030 ($ millions)
 Figure 68. France Peptide API CDMO Services Market Size 2025-2030 ($ millions)
 Figure 69. UK Peptide API CDMO Services Market Size 2025-2030 ($ millions)
 Figure 70. Italy Peptide API CDMO Services Market Size 2025-2030 ($ millions)
 Figure 71. Russia Peptide API CDMO Services Market Size 2025-2030 ($ millions)
 Figure 72. Egypt Peptide API CDMO Services Market Size 2025-2030 ($ millions)
 Figure 73. South Africa Peptide API CDMO Services Market Size 2025-2030 ($ millions)
 Figure 74. Israel Peptide API CDMO Services Market Size 2025-2030 ($ millions)
 Figure 75. Turkey Peptide API CDMO Services Market Size 2025-2030 ($ millions)
 Figure 76. GCC Countries Peptide API CDMO Services Market Size 2025-2030 ($ millions)
 Figure 77. Global Peptide API CDMO Services Market Size Market Share Forecast by Type (2025-2030)
 Figure 78. Global Peptide API CDMO Services Market Size Market Share Forecast by Application (2025-2030)

Companies Mentioned

Bachem

PolyPeptide

CordenPharma

AmbioPharm

USV Peptides

Thermo Fisher

Bio Basic

JPT

Genscript

Chinese Peptide Company

ScinoPharm

ChengDu ShengNuo Biotec

CBL

Piramal Pharma

CPC Scientific

Methodology

LP Information presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

Data Sourse

Primary Source

Secondary Source

Players/Suppliers

Journals and Periodicals

Industry Experts

Government Bodies

Distributors/Traders

Annual Reports

Opinion Leaders

Presentations

Front-line Staff